Table 1 Clinical and histopathologic parameters (patients with tumour resection: 36)

From: Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer

Parameter

Subtype

Number

%

Histology

Squamous

23

63.9

 

Adeno

13

36.1

ypT-categorya

T0

2

5.6

 

T1

1

2.8

 

T2

7

19.4

 

T3

25

69.4

 

T4

1

2.8

ypN-categoryb

N0

15

41.7

 

N1

21

58.3

R-categoryc

R0

31

86.1

 

R1

5

13.9

 

R2

0

0

Grading

G1

0

0

 

G2

12

33.3

 

G3

24

66.7

Regression graded

I

15

41.7

 

II

9

25

 

III

10

27.8

 

IV

2

5.6

  1. aHistopathologic tumour category after neoadjuvant therapy according to UICC (Union Internationale Contre Le Cancer, 5th edition, 1997).
  2. bHistopathologic lymph node category after neoadjuvant therapy according to UICC (Union Internationale Contre Le Cancer, 5th edition, 1997).
  3. cResidual tumour category according to UICC (Union Internationale Contre Le Cancer, 5th edition, 1997).
  4. dGrade I: >50% vital residual tumour cells (VRTC), grade II: 10–50% VRTC, grade III: nearly complete response (NCR) with <10% VRTC and grade IV: complete response (pCR, ypT0).